HR 4402
118th Congress
House
Health
Health technology, devices, supplies
Manufacturing
Medicaid
Medicare
Poverty and welfare assistance
Prescription drugs
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
Introduced: June 30, 2023
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jul 7, 2023
Referred to the Subcommittee on Health.
Jun 30, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 30, 2023
Introduced in House
Plain-English summary
This bill specifies that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4
Cosponsors
1